StockData

Cartesian Therapeutics, Inc. (RNAC) stock

RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$6.30+0.18 (+2.94%)

Close on Nov 18, 2026Market cap $190.61MP/E –Yield –

Cartesian Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Cartesian Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $1.48M. For fiscal 2025 it was $2.80M, down 92.8% from the year before. Over ten years it grew -7.4% a year on average. The highest annual figure on record is $110.78M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.80M-92.8%
FY2024Dec 31, 2024$38.91M+49.6%
FY2023Dec 31, 2023$26.00M-76.5%
FY2022Dec 31, 2022$110.78M+30.2%
FY2021Dec 31, 2021$85.08M+412.6%
FY2020Dec 31, 2020$16.60M+148.6%
FY2019Dec 31, 2019$6.68M+639.4%
FY2018Dec 31, 2018$903.00K+336.2%
FY2017Dec 31, 2017$207.00K-97.4%
FY2016Dec 31, 2016$8.08M+34.5%
FY2015Dec 31, 2015$6.01M+97.7%
FY2014Dec 31, 2014$3.04M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$78.00K-92.9%
Q4 FY2025Dec 31, 2025$947.00K+144.7%
Q3 FY2025Sep 30, 2025$452.00K-98.6%
Q2 FY2025Jun 30, 2025$298.00K-94.9%
Q1 FY2025Mar 31, 2025$1.10M-86.7%
Q3 FY2024Sep 30, 2024$387.00K-94.1%
Q2 FY2024Jun 30, 2024$33.45M+537.2%
Q1 FY2024Mar 31, 2024$5.84M-1.7%
Q4 FY2023Dec 31, 2023$8.27M-50.8%
Q3 FY2023Sep 30, 2023$6.55M-68.4%
Q2 FY2023Jun 30, 2023$5.25M-86.6%
Q1 FY2023Mar 31, 2023$5.94M-82.5%
Q4 FY2022Dec 31, 2022$16.80M-43.9%
Q3 FY2022Sep 30, 2022$20.71M-15.2%
Q2 FY2022Jun 30, 2022$39.27M+99.7%
Q1 FY2022Mar 31, 2022$34.00M+207.7%
Q4 FY2021Dec 31, 2021$29.94M+150.5%
Q3 FY2021Sep 30, 2021$24.43M+425.8%
Q2 FY2021Jun 30, 2021$19.66M–
Q1 FY2021Mar 31, 2021$11.05M–
Q4 FY2020Dec 31, 2020$11.95M+79.6%
Q3 FY2020Sep 30, 2020$4.65M–
Q2 FY2020Jun 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$0-100.0%
Q4 FY2019Dec 31, 2019$6.65M+636.9%
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$13.00K–
Q1 FY2019Mar 31, 2019$10.00K–
Q4 FY2018Dec 31, 2018$903.00K+5211.8%
Q3 FY2018Sep 30, 2018$0-100.0%
Q2 FY2018Jun 30, 2018$0-100.0%
Q1 FY2018Mar 31, 2018$0-100.0%
Q4 FY2017Dec 31, 2017$17.00K-99.4%
Q3 FY2017Sep 30, 2017$27.00K-97.4%
Q2 FY2017Jun 30, 2017$26.00K–
Q1 FY2017Mar 31, 2017$137.00K–
Q4 FY2016Dec 31, 2016$2.93M–
Q3 FY2016Sep 30, 2016$1.05M–

More Cartesian Therapeutics figures

See a number that looks wrong?